Population
HEK-293 T cells
Design
Preclinical
Authors
Loading...
pA104R IFN antagonism is hypothesis-generating for ASFV immune evasion; leaves open in vivo relevance and therapeutic targeting.
ASFV pA104R protein acts as a potent antagonist of type I interferon signaling by attenuating STAT1 phosphorylation.
Chen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: